Wyeth Sues To Protect Its Best-Selling Drug

Law360, New York (April 23, 2007, 12:00 AM EDT) -- Wyeth has filed a patent infringement suit against Osmotica Pharmaceutical Corp., accusing Osmotica of seeking regulatory approval to market a knockoff of the extended-release form of Wyeth’s blockbuster depression and anxiety treatment Effexor.

Wyeth filed the suit Friday in the U.S. District Court for the Eastern District of North Carolina. In a variation on the familiar story of a patent holder suing to protect the market for a branded drug after a generic competitor files an Abbreviated New Drug Application (ANDA), Wyeth’s suit centers on a...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.